Summit Therapeutics Inc. (SMMT) — Operating Income

Annual figures by fiscal year, from SEC filings.

2019: $5.39M2020: -$53.19M2021: -$86.19M2022: -$72.09M2023: -$609.65M2024: -$226.00M-$226.00M
2019Operating Income (USD)2024
Fiscal YearOperating IncomeChange YoY
2024-$226.00M+62.9%
2023-$609.65M-745.7%
2022-$72.09M+16.4%
2021-$86.19M-62.0%
2020-$53.19M-1087.1%
2019$5.39M